Biopharmaceutical Tubing Market Research Report and Outlook by 2028

The biopharmaceutical tubing market is projected to grow significantly, reaching approximately US$ 6,013.27 million by 2028, up from US$ 3,442.82 million in 2021. This growth represents a compound annual growth rate (CAGR) of 8.3% from 2021 to 2028.

Several factors are driving this market expansion, including the increasing elderly population worldwide and the rising demand for minimally invasive medical procedures. However, the growth of the biopharmaceutical tubing market is somewhat constrained by stringent regulatory requirements.

Biopharmaceutical tubing is specifically engineered to cater to the essential needs of the biopharmaceutical and medical sectors. This tubing is manufactured through an extrusion process and finds extensive application in drug delivery systems, feeding tubes, and peristaltic pumps. It is also utilized in various minimally invasive applications, such as stent delivery systems, cardiovascular catheters, and urological retrieval devices. Additionally, these tubes are integral to anesthesiology and respiratory equipment, intravenous (IV) systems, and biopharmaceutical laboratory apparatus, offering exceptional thermal, mechanical, and chemical properties.

The increase in life expectancy has resulted in a growing geriatric population globally. According to the World Health Organization (WHO), the proportion of individuals aged over 60 is expected to nearly double from 12% in 2015 to 22% by 2050. The United Nations' World Population Ageing 2017 report indicated that in 2017, there were approximately 962 million people aged 60 and above, a figure projected to reach around 2.1 billion by 2050. In the United States, the Census Bureau forecasts that the population aged 65 and older will increase from 46 million in 2016 to over 98 million by 2060, with their share of the total population rising from about 15% to 24%.

In Europe, the percentage of individuals over 60 was the highest at 25% in 2017. Other regions are also witnessing rapid aging, and by 2050, all areas except Africa are expected to have at least a quarter of their populations aged 60 and older. The global geriatric population is anticipated to reach 1.4 billion by 2030, 2.1 billion by 2050, and exceed 3.1 billion by 2100.

This demographic shift has led to an increase in age-related health issues, thereby driving demand for diagnostic tools and drug delivery systems. There is also a notable rise in urological conditions necessitating catheterization, with healthcare professionals advocating for self-catheterization to minimize costs, reduce hospital stays, and lower the risk of healthcare-associated infections (HAIs). Aging is a significant contributor to the prevalence of chronic diseases, which often require interventions that lead to ICU admissions. Consequently, the rapid growth of the elderly population correlates directly with the rising need for medical devices that utilize tubing, including drug delivery systems, dialysis, cardiac bypass, peristaltic pumps, and sterile filling and dispensing systems, thus propelling the adoption of biopharmaceutical tubing.

Type Insights

The global biopharmaceutical tubing market is categorized by type into plastic, metal, and silicone. In 2020, the silicone segment dominated the market share and is projected to experience the highest CAGR from 2021 to 2028. The biocompatibility of silicone makes it suitable for contact with human tissues and bodily fluids, enhancing its application in medical tubing. Its properties, including high temperature and chemical resistance, mechanical strength, and electrical characteristics, make it a preferred material in biological applications.

Application Insights

In terms of application, the biopharmaceutical tubing market is divided into pharmaceutical, medical devices, research and development, and other categories. The pharmaceutical segment, which includes single-use technology and other applications, held the largest market share in 2020 and is expected to maintain its leading position by 2028. Liquid transfer is a critical component of pharmaceutical manufacturing processes, such as the production of cough syrups and complex active pharmaceutical ingredients (APIs) like vaccines and cancer treatments. This transfer must occur in a highly regulated environment, leading to an increased demand for ultra-pure and corrosion-resistant tubing systems capable of withstanding harsh chemical environments, thereby driving growth in this segment.

Key sources referenced in the preparation of this report on the global biopharmaceutical tubing market include the United States Pharmacopeia (USP), Watson-Marlow Fluid Technology Group (WMFTG), The Italian Institute of Statistics (ISTAT), the Asthma and Immunology Society, the United Nations' World Population Ageing 2017 report, and the US Census Bureau.